Cynosure Inc (CYNO) SEC Filing 10-Q Quarterly report for the period ending Wednesday, September 30, 2015

Exhibit 99.1

Contact:

Cynosure Announces Third-Quarter 2015 Results;

Revenue of $78.4 Million, 10 Percent Increase from

Prior Year

Third-Quarter Highlights:

Westford, MA – October 27, 2015 – Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended September 30, 2015.

“Continued momentum in North America drove another quarter of strong top-line growth and increased gross margin for Cynosure,” said Chief Executive Officer Michael Davin. “Product revenue in North America was up 29 percent year-over-year to $40.8 million, or 63 percent of total product revenue for the quarter, on strong sales of the PicoSure, Icon and MonaLisa Touch product lines. International product revenue was essentially flat for the quarter compared with the third quarter of 2014 as a result of unfavorable foreign currency exchange rates, as well as continued economic weakness in Europe and China. On a constant currency basis, international product revenue was up 6 percent year-over-year.

“As we discussed during our September 15^th Investor Day, the U.S. pre-launch release of SculpSure, our new hyperthermic laser system for non-invasive fat reduction, is underway,” Davin said. “We have begun initial shipments of the system and conducted sales training with personnel in a number of key territories. Systems have also been placed with several industry luminaries, and the feedback from these physicians and their patients has been excellent. SculpSure was demonstrated at the American Society for Dermatologic Surgery Annual Meeting in Chicago and the 2015 meeting of the American Society of Plastic Surgeons in Boston. Internationally, SculpSure was unveiled at this month’s 25^th European Academy of Dermatology and Venereology Congress in Copenhagen. In addition, we have conducted training for our direct sales offices in Europe and Australia.”